SAN DIEGO--(BUSINESS WIRE)--Nov 3, 2023--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or 鈥淐alidi鈥�), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the presentation of new preclinical data from the company鈥檚 CLD-201 ...
MARSEILLE, France--(BUSINESS WIRE)--Nov 3, 2023--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (鈥� <em>Innate</em> 鈥� or the 鈥� <em>Company</em> 鈥�) today announced that several abstracts, including one oral presentation, have ...
Two fully funded pilot studies to treat cancer free for pet owners who bring their dogs to research sites.PHILADELPHIA, Nov. 2, 2023 /PRNewswire/ -- Vetigenics, a clinical-stage biopharmaceutical company advancing antibody-based therapies for pets, announces that the first canine patient with ...
BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 2, 2023--Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments. The expanded ...
